AIDS: Clinical Trials

12 trials for AIDS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 12
Phase 23Completed 3

Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease
N-803 - Hiv, HIV Infections
Phase 1CompletedUniversity of Minnesota102021-04-012024-04-02
Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults
Ad35-GRIN, MVA.HIVconsv, pSG2.HIVconsv DNA - AIDS
Phase 1 / Phase 2CompletedUniversity of Oxford722014-03-012016-05-30
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Extended-Release Naltrexone - HIV, AIDS
Phase 1 / Phase 2CompletedYale University1512011-03-012020-03-19
Study Targeting Affect Regulation
Resilient Affective Processing Therapy (RAPT) - HIV, AIDS
Phase 1 / Phase 2CompletedUniversity of California, San Francisco562010-09-012014-10-27
Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Blood collection, GSK HIV vaccine 732462 - AIDS
Phase 1CompletedGlaxoSmithKline1902010-03-222018-03-02
Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old
HIV Vaccine 732462, Placebo vaccine - AIDS
Phase 1CompletedGlaxoSmithKline412009-02-032018-06-18
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer
Efavirenz; Tenofovir disoproxil fumarate; Telaprevir - Hepatitis C, HCV
Phase 1CompletedTibotec BVBA202009-02-012010-12-17
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
TMC125 - HIV, AIDS
Phase 1CompletedTibotec Pharmaceuticals, Ireland182008-09-012011-06-09
TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.
Darunavir - HIV, AIDS
Phase 1CompletedTibotec Pharmaceuticals, Ireland212008-08-012011-06-09
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
TMC278 - HIV, AIDS
Phase 1CompletedTibotec Pharmaceuticals, Ireland182008-07-012010-04-28
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
TMC278 - HIV, AIDS
Phase 1CompletedTibotec Pharmaceuticals, Ireland322008-06-012010-04-28
Study of Enfuvirtide in HIV-Positive Subjects
Fuzeon - HIV Infections, AIDS
Phase 1CompletedTrimeris262005-06-24

Narrower conditions

Acquired Immunodeficiency Syndrome (12)  ·  HIV Infections (5)  ·  Substance-Related Disorders (2)  ·  Hepatitis C (1)  ·  Mycoses (1)  ·  Opioid-Related Disorders (1)  ·  Wounds and Injuries (1)

Broader conditions

Blood-Borne Infections (12)  ·  Communicable Diseases (12)  ·  Genital Diseases (12)  ·  Immune System Diseases (12)  ·  Immunologic Deficiency Syndromes (12)  ·  Infections (12)  ·  Lentivirus Infections (12)  ·  RNA Virus Infections (12)  ·  Retroviridae Infections (12)  ·  Sexually Transmitted Diseases (12)  ·  Sexually Transmitted Diseases, Viral (12)  ·  Slow Virus Diseases (12)  ·  Urogenital Diseases (12)  ·  Virus Diseases (12)  ·  HIV Infections (7)

Interventions

Rilpivirine (2)  ·  ALT-803 (1)  ·  Blood Specimen Collection (1)  ·  Darunavir (1)  ·  Enfuvirtide (1)  ·  Naltrexone (1)  ·  Tenofovir (1)  ·  efavirenz (1)  ·  etravirine (1)  ·  telaprevir (1)  ·  vivitrol (1)

Sponsors

Tibotec Pharmaceuticals, Ireland (4)  ·  GlaxoSmithKline (2)  ·  Tibotec BVBA (1)  ·  Trimeris (1)  ·  University of California, San Francisco (1)  ·  University of Minnesota (1)  ·  University of Oxford (1)  ·  Yale University (1)

Countries

United States (5)  ·  Germany (2)  ·  France (1)  ·  Kenya (1)  ·  Spain (1)

Top investigators

Adam Carrico, PhD (1)  ·  Frederick L Altice (1)  ·  Sandra A Springer, MD (1)  ·  Timothy Schacker, MD (1)  ·  Walter Jaoko (1)

Results publications

PMID 23400742, PMID 24144472, PMID 24161160, PMID 24674234, PMID 26560326, PMID 29373393, PMID 29606517, PMID 40342086, PMID 40471871

NIH funding

2009 (1), 5UM1AI126611 (1), K02DA032322 (1)